Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
707.10
+8.50 (1.22%)
At close: Jan 19, 2026
0.53%
Market Cap1.70B
Revenue (ttm)193.90M
Net Income (ttm)4.82M
Shares Out2.40M
EPS (ttm)2.01
PE Ratio353.10
Forward PEn/a
Dividend1.00 (0.14%)
Ex-Dividend DateNov 23, 2025
Volume698
Average Volume538
Openn/a
Previous Close698.60
Day's Range705.50 - 716.00
52-Week Range680.20 - 947.90
Beta-0.43
RSI47.00
Earnings DateJan 21, 2026

About Ambee Pharmaceuticals

Ambee Pharmaceuticals PLC engages in the manufacture, buy, sell, export, or deal in drugs, medicines, pharmaceuticals, chemicals, medical, and other preparations in Bangladesh. The company offers tablets, capsules, liquids, gel in tubes, and injectables for therapeutic areas, such as antiulcerant, antacid, antibacterial, antifungal, anti-protozoal, anti-helmintic, antituberculer, antispasmodic, antiasthmatic and antitussive, and analgesic and antipyretic. It also provides products for therapeutic areas in non-steroidal anti-inflammatory, steroi... [Read more]

Industry Pharmaceutical Preparations
Founded 1976
Employees 474
Stock Exchange Dhaka Stock Exchange
Ticker Symbol AMBEEPHA
Full Company Profile

Financial Performance

In 2025, Ambee Pharmaceuticals's revenue was 230.55 million, an increase of 5.13% compared to the previous year's 219.30 million. Earnings were 5.31 million, a decrease of -45.17%.

Financial Statements